TIR-Domain-Containing Adapter-Inducing Interferon- β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine
Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regu...
Saved in:
Published in | Journal of clinical & cellular immunology Vol. 7; no. 5 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regulated by innate immunity, we addressed whether TRIF signaling regulates Tfh cell differentiation and its ability to trigger humoral immune responses in the intestine.
CD4
CXCR5
T cells, B cells, and plasma cells in the Peyer's patches (PPs) of WT and TRIF-deficient (Trif
) mice were analyzed by flow cytometry at the baseline, 9 days post primary infection, and 7 days post-secondary infection with
.
-specific CD4
CXCR5
T cells were generated
by co-culturing peritoneal macrophages with splenic naïve T cells in the presence of
lysate. WT and Trif
mice received CD4
CXCR5
T cells isolated either from
-primed WT mice or generated
. These mice were infected with
and followed up to 4 weeks.
-specific IgA and IgG were measured in stool and serum samples, respectively.
At baseline, CD4
CXCR5
T cell proportion was higher but the proportion of B cells and plasma cells was lower in the PPs of Trif
mice compared to WT mice. After infection, the proportion of plasma cells also became higher in the PPs of Trif
mice compared to WT mice. Corresponding increase of
-specific stool IgA but not serum IgG was found in Trif
mice compared to WT mice. Both
isolated and
generated CD4
CXCR5
T cells induced protective immunity against
infection.
Our results reveal a novel role of TRIF in the regulation of humoral immunity in the intestine that can be utilized as a basis for a unique vaccine strategy. |
---|---|
AbstractList | Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regulated by innate immunity, we addressed whether TRIF signaling regulates Tfh cell differentiation and its ability to trigger humoral immune responses in the intestine.
CD4
CXCR5
T cells, B cells, and plasma cells in the Peyer's patches (PPs) of WT and TRIF-deficient (Trif
) mice were analyzed by flow cytometry at the baseline, 9 days post primary infection, and 7 days post-secondary infection with
.
-specific CD4
CXCR5
T cells were generated
by co-culturing peritoneal macrophages with splenic naïve T cells in the presence of
lysate. WT and Trif
mice received CD4
CXCR5
T cells isolated either from
-primed WT mice or generated
. These mice were infected with
and followed up to 4 weeks.
-specific IgA and IgG were measured in stool and serum samples, respectively.
At baseline, CD4
CXCR5
T cell proportion was higher but the proportion of B cells and plasma cells was lower in the PPs of Trif
mice compared to WT mice. After infection, the proportion of plasma cells also became higher in the PPs of Trif
mice compared to WT mice. Corresponding increase of
-specific stool IgA but not serum IgG was found in Trif
mice compared to WT mice. Both
isolated and
generated CD4
CXCR5
T cells induced protective immunity against
infection.
Our results reveal a novel role of TRIF in the regulation of humoral immunity in the intestine that can be utilized as a basis for a unique vaccine strategy. OBJECTIVEEstablishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5 expressing T helper cells that induce antigen-specific B cell differentiation. Because the differentiation of T helper cells is largely regulated by innate immunity, we addressed whether TRIF signaling regulates Tfh cell differentiation and its ability to trigger humoral immune responses in the intestine. METHODCD4+CXCR5+ T cells, B cells, and plasma cells in the Peyer's patches (PPs) of WT and TRIF-deficient (TrifLPS2) mice were analyzed by flow cytometry at the baseline, 9 days post primary infection, and 7 days post-secondary infection with Y. enterocolitica. Y. enterocolitica-specific CD4+CXCR5+ T cells were generated in vitro by co-culturing peritoneal macrophages with splenic naïve T cells in the presence of Y. enterocolitica lysate. WT and TrifLPS2 mice received CD4+CXCR5+ T cells isolated either from Y. enterocolitica-primed WT mice or generated in vitro. These mice were infected with Y. enterocolitica and followed up to 4 weeks. Y. enterocolitica-specific IgA and IgG were measured in stool and serum samples, respectively. RESULTSAt baseline, CD4+CXCR5+ T cell proportion was higher but the proportion of B cells and plasma cells was lower in the PPs of TrifLPS2 mice compared to WT mice. After infection, the proportion of plasma cells also became higher in the PPs of TrifLPS2 mice compared to WT mice. Corresponding increase of Y. enterocolitica-specific stool IgA but not serum IgG was found in TrifLPS2 mice compared to WT mice. Both in vivo isolated and in vitro generated CD4+CXCR5+ T cells induced protective immunity against Y. enterocolitica infection. CONCLUSIONOur results reveal a novel role of TRIF in the regulation of humoral immunity in the intestine that can be utilized as a basis for a unique vaccine strategy. |
Author | Flores, Claudia Ruiz, Jose Hyun, Jinhee Kanagavelu, Saravana Sun, Frank Cho, Ei E Romero, Laura Fukata, Masayuki Hagiwara, Shinichiro Shih, David Q |
AuthorAffiliation | 4 Department of Microbiology & Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA 3 Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA 2 Division of Infectious Diseases and Immunology, Department of Biomedical Science, Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA 1 Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA |
AuthorAffiliation_xml | – name: 1 Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – name: 3 Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA – name: 4 Department of Microbiology & Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA – name: 2 Division of Infectious Diseases and Immunology, Department of Biomedical Science, Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA |
Author_xml | – sequence: 1 givenname: Saravana surname: Kanagavelu fullname: Kanagavelu, Saravana organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Division of Infectious Diseases and Immunology, Department of Biomedical Science, Medicine and Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 2 givenname: Claudia surname: Flores fullname: Flores, Claudia organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 3 givenname: Shinichiro surname: Hagiwara fullname: Hagiwara, Shinichiro organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 4 givenname: Jose surname: Ruiz fullname: Ruiz, Jose organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 5 givenname: Jinhee surname: Hyun fullname: Hyun, Jinhee organization: Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA – sequence: 6 givenname: Ei E surname: Cho fullname: Cho, Ei E organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 7 givenname: Frank surname: Sun fullname: Sun, Frank organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 8 givenname: Laura surname: Romero fullname: Romero, Laura organization: Department of Microbiology & Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA – sequence: 9 givenname: David Q surname: Shih fullname: Shih, David Q organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA – sequence: 10 givenname: Masayuki surname: Fukata fullname: Fukata, Masayuki organization: Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation, Inflammatory Bowel and Immunology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Cell Biology, University of Miami Miller School of Medicine, Miami, Florida, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27853628$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUNtKw0AQXaRia-0H-CL7WJHU3exusnkRSrQaKAghgm9hk0zaSLKJuQj-lh_iN7lqLfXpzJk5c-Zyika61oDQOSULTl372qZCWJ70vAUlhHAhj9BknxsdxGM067oXoyHMUCZO0Nh2pWCOLSeoioLQuq0rVWjLr3VvsNAbvMxU00NrBTob0u9EoA3Noa21hT8_8DwKg9UlDmEzlKqHDvvPfiiucIS3UDbQYh_KssOFxv0Wfpq7vtBwho5zVXYw2-EUPa3uIv_BWj_eB_5ybTWUUsfi0nZs4BnPqKTEy1NI3STnjDiEQwqeINIolJdQnjCSCoemjDHCpQtMgaPYFN38-jZDUkGWgu5bVcZNW1SqfY9rVcT_K7rYxpv6LRaUSCEdYzDfGbT162CWj6uiS81NSkM9dDGVnFImhUuM9OJw1n7I34_ZFyEegGM |
ContentType | Journal Article |
DBID | NPM 7X8 5PM |
DOI | 10.4172/2155-9899.1000458 |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2155-9899 |
ExternalDocumentID | 27853628 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI095255 – fundername: NIAID NIH HHS grantid: R56 AI095255 |
GroupedDBID | 8TZ ALMA_UNASSIGNED_HOLDINGS KQ8 NPM OK1 7X8 5PM |
ID | FETCH-LOGICAL-p1116-48262e4d4d18109fcec7bf430604ece9508826a9b14b30c561c3330487e3ae6a3 |
ISSN | 2155-9899 |
IngestDate | Fri Sep 01 02:38:27 EDT 2023 Fri Jun 28 17:01:38 EDT 2024 Fri Sep 17 20:16:47 EDT 2021 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Keywords | Bacterial infection Intestine Mucosal vaccine Plasma cells Innate immunity B cells Enterocolitis T follicular helper cells |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p1116-48262e4d4d18109fcec7bf430604ece9508826a9b14b30c561c3330487e3ae6a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 27853628 |
PQID | 1841138570 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5108586 proquest_miscellaneous_1841138570 pubmed_primary_27853628 |
PublicationCentury | 2000 |
PublicationDate | 2016-Oct |
PublicationDateYYYYMMDD | 2016-10-01 |
PublicationDate_xml | – month: 10 year: 2016 text: 2016-Oct |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of clinical & cellular immunology |
PublicationTitleAlternate | J Clin Cell Immunol |
PublicationYear | 2016 |
References | 27096318 - Immunity. 2016 Apr 19;44(4):875-88 25631080 - J Virol. 2015 Apr;89(8):4158-69 25620548 - Cell Host Microbe. 2015 Feb 11;17(2):153-63 15606348 - Expert Rev Vaccines. 2004 Dec;3(6):643-54 27120165 - Nature. 2016 May 5;533(7601):42-3 25699040 - Front Immunol. 2015 Feb 02;6:16 19741596 - Mucosal Immunol. 2009 Nov;2(6):495-503 19234155 - J Immunol. 2009 Mar 1;182(5):2610-9 26907215 - Annu Rev Immunol. 2016 May 20;34:335-68 10523610 - J Exp Med. 1999 Oct 18;190(8):1123-34 11104797 - J Exp Med. 2000 Dec 4;192(11):1545-52 18522803 - Gastroenterology. 2008 Aug;135(2):529-38 15841100 - Nat Rev Immunol. 2005 May;5(5):413-20 18941235 - J Immunol. 2008 Nov 1;181(9):6447-55 12154359 - Nat Immunol. 2002 Sep;3(9):822-9 26583099 - Biomed Res Int. 2015;2015:314620 9743536 - J Exp Med. 1998 Sep 21;188(6):1185-90 11104798 - J Exp Med. 2000 Dec 4;192(11):1553-62 21423809 - PLoS One. 2011 Mar 14;6(3):e17739 17325052 - Infect Immun. 2007 May;75(5):2234-43 16048541 - Immunol Rev. 2005 Aug;206:32-63 22124111 - J Exp Med. 2011 Dec 19;208(13):2705-16 22825288 - Curr Opin Infect Dis. 2012 Oct;25(5):489-99 22910541 - PLoS Pathog. 2012;8(7):e1002785 26351279 - Infect Immun. 2015 Nov;83(11):4404-15 21827802 - Adv Drug Deliv Rev. 2012 May 1;64(6):523-30 14625548 - Nat Immunol. 2003 Dec;4(12):1223-9 25902362 - Vaccine. 2015 Jun 19;33 Suppl 3:C36-41 19075245 - Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20858-63 26106395 - Front Immunol. 2015 Jun 08;6:296 12615891 - Annu Rev Immunol. 2003;21:685-711 9343353 - Annu Rev Microbiol. 1997;51:311-40 22674334 - Science. 2012 Jun 8;336(6086):1268-73 23230002 - J Exp Med. 2012 Dec 17;209(13):2367-81 24914172 - Int Immunol. 2014 Sep;26(9):517-28 17570691 - Immunity. 2007 Jun;26(6):812-26 23475182 - Nat Immunol. 2013 Apr;14(4):372-9 12427767 - Annu Rev Immunol. 2003;21:231-64 15343369 - Nat Rev Immunol. 2004 Sep;4(9):699-710 11413192 - J Exp Med. 2001 Jun 18;193(12):1373-81 24489092 - J Immunol. 2014 Mar 1;192(5):2156-66 25879814 - Curr Opin Immunol. 2015 Jun;34:130-6 23688737 - Curr Opin Immunol. 2013 Jun;25(3):366-72 |
References_xml | |
SSID | ssj0000398935 |
Score | 2.0144787 |
Snippet | Establishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum of CXCR5... OBJECTIVEEstablishing an effective humoral immunity is an important host defense mechanism in intestinal mucosa. T follicular helper (Tfh) cells are a spectrum... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
Title | TIR-Domain-Containing Adapter-Inducing Interferon- β (TRIF) Regulates CXCR5+ T helper Cells in the Intestine |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27853628 https://search.proquest.com/docview/1841138570 https://pubmed.ncbi.nlm.nih.gov/PMC5108586 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkBA3iH-6ATISlUCRR34cJ7ncwqaNaUiUTupd5SQujZQmVduAtJfhHXgQnolz4iRNR5GAm6hyXDvy-XT8-fj8EPJa-Lip2BYTiVSMSy9iPncDFgTS4R53TTvCAOfLj-Lsin8Yu-Ne73vHa6lcR4fx9c64kv-RKrSBXDFK9h8k2w4KDfAb5AtPkDA8_07G50P2vpjD4Z5hlild7ME4SuQCVothVY5YOwRgLWq1LHJmDMKTwbGNvHI0PD9Fm8BQV6NXKyMch0N3YB8bI-CP2UItjVBl2apxhcRhQCHk285DG0LbBlkimvBCQHu4YgDKlu3-Aj1u5FeVlY1JGgs7b4BULLXqCjNZJqnc6Mgv6TdZlUUyPs9wqlm6LNoLozK9bm40upYMS7Q-cbXCA_bhssDXBZMO1Y62WmN7HWC6u_YBDrQMQ12aP6MvCN4Id_uCKBfzChi2B5xF1DHq28m3m1e3yG0bNBmq0ItPfmvEMx0YvSri2k6lb87xA979Nj1mnq4H3HWguemX2yE6o_vkXi1QeqTh9oD0VP6Q3LmsfTAekflO1NGbqKMd1NGfP-gbxNtb2qKNVmgz6IhqrNEKazTNKWCNtlh7TK5OT0bhGauLdrAFbJuCcTiv2oonPAHuaAbTWMVeNOUOJmlSsaqKDttCBpHFI8eMgb7HDtrUfE85UgnpPCF7eZGrZ4Sa2Fk6nskTyUUcRUD3zVgmbiITGYlpn7xq1nACShGBLXNVlKuJ5XPLcrB2Q5881Ws6WejsLZNGAn3iba122wETrm-_ydNZlXjdxVAdX-z_ccwDcncD7Odkb70s1QsgrevoZQWcX_DBkf0 |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TIR-Domain-Containing+Adapter-Inducing+Interferon-+%CE%B2+%28TRIF%29+Regulates+CXCR5%2B+T+helper+Cells+in+the+Intestine&rft.jtitle=Journal+of+clinical+%26+cellular+immunology&rft.au=Kanagavelu%2C+Saravana&rft.au=Flores%2C+Claudia&rft.au=Hagiwara%2C+Shinichiro&rft.au=Ruiz%2C+Jose&rft.date=2016-10-01&rft.issn=2155-9899&rft.eissn=2155-9899&rft.volume=7&rft.issue=5&rft_id=info:doi/10.4172%2F2155-9899.1000458&rft_id=info%3Apmid%2F27853628&rft.externalDocID=27853628 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2155-9899&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2155-9899&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2155-9899&client=summon |